Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

by Stephen D. Silberstein, Virginia L. Stauffer, Katie A. Day, Sarah Lipsius, Maria-Carmen Wilson
Published 2019-06-01

Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

by Stephen D. Silberstein, Virginia L. Stauffer, Katie A. Day, Sarah Lipsius, Maria-Carmen Wilson
Published 2019-12-01

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

by Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina, Zaza Katsarava
Published 2020-09-01

Acetate causes alcohol hangover headache in rats.

by Christina R Maxwell, Rebecca Jay Spangenberg, Jan B Hoek, Stephen D Silberstein, Michael L Oshinsky
Published 2010-12-01

Treatment patterns of patients diagnosed with major headache disorders: A retrospective claims analysis

by David Kudrow, Sagar Munjal, Leah Bensimon, Tasneem Lokhandwala, Binglin Yue, Anna D’Souza Coutinho, Stephen D Silberstein
Published 2020-03-01

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials

by Stephen D. Silberstein, Joshua M. Cohen, Ronghua Yang, Sanjay K. Gandhi, Evelyn Du, Adelene E. Jann, Michael J. Marmura
Published 2021-01-01

EFFICACY AND TOLERABILITY OF STOPAIN FOR A MIGRAINE ATTACK

by Andrea eSt. Cyr, Ashley eChen, Kathleen C. Bradley, Hsiangkuo eYuan, Stephen D. Silberstein, William B. Young
Published 2015-02-01

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis

by Hans-Christoph Diener, David W. Dodick, Richard B. Lipton, Aubrey Manack Adams, Ronald E. DeGryse, Stephen D. Silberstein
Published 2020-10-01

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine

by Stephen D. Silberstein, Hans-Christoph Diener, David W. Dodick, Aubrey Manack Adams, Ronald E. DeGryse, Richard B. Lipton
Published 2020-10-01

Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data

by David W. Dodick, Anand S. Shewale, Richard B. Lipton, Seth J. Baum, Steven C. Marcus, Stephen D. Silberstein, Jelena M. Pavlovic, Nathan L. Bennett, William B. Young, Hema N. Viswanathan, Jalpa A. Doshi, Howard Weintraub
Published 2020-10-01